Doxycycline In Pityriasis Rosea: Placebo- Controlled Clinical Trial
Background: Pityriasis rosea is an acute, self-limiting skin disease, probably of infective origin. Doxycycline is a broad-spectrum antibiotic, and most probably has an immunomodulator and an anti-inflammatory effect. Objective: To assess the efficacy of doxycycline in the treatment of pityriasis ro...
Main Authors: | Ghassaq Al-Timimi, Sabeeh Al-Mashhadani, Makram Al-Waiz |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Medicine University of Baghdad
2007-04-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1434 |
Similar Items
-
Pitiríase rósea Pityriasis rosea
by: Sandra Maria Bitencourt Miranda, et al.
Published: (2008-10-01) -
Efficacy of Erythromycin in treatment of pityriasis rosea (A double-blind, placebo-controlled clinical trial)
by: Mohammad Dehghan, et al.
Published: (2008-04-01) -
Unilateral pityriasis rosea in a child: A rare clinical presentation
by: Atiye Oğrum
Published: (2017-04-01) -
Giant pityriasis rosea
by: Zawar Vijay
Published: (2010-01-01) -
A clinical study on pityriasis rosea
by: Egwin Anand, et al.
Published: (2005-01-01)